Join us at World CB & CDx 2024

First AI pathology Solution Deployed for Prospective Trial Enrollment

Enabling next-gen diagnostics for ADCs, multi-specifics, and IO.

Panel Discussion:

AI and Digital Pathology – Enabling Next-Gen Treatments & Diagnostics

Discussion Topics

  1. What impact does artificial intelligence (AI) and digital pathology (DP) have on biomarker strategy and drug development?
  2. How are novel treatment modalities driving innovative assays and AI-powered scoring frameworks?
  3. How can AI-powered biomarkers be deployed for trial enrollment and patient selection?

Moderator

Oscar Puig, PhD

VP Translational Medicine & Diagnostics

Nucleai

Panelist

Christine Ward, PhD

Head of Translational Medicine

Moderna

Mark Gustavson, PhD

Head of Computational Pathology & Translational Medicine

AstraZeneca

Rolando Yanes, PhD

Global Diagnostics Lead

Amgen

Book a Meeting with Us

Oscar Puig, PhD

VP Translational Medicine & Diagnostics

Jonathan Daniels

SVP Strategy & BD

Martin Koch

Director of Business Development

Vikas Ahuja

VP Strategic Partnerships

Please complete the form below to schedule a meeting with our team at World CB & CDx 2024